NEW CLINICAL DATA PRESENTED AT TRANSCATHETER CARDIOVASCULAR THERAPEUTICS 2005 SUPPORTS USE OF BIOLIMUS A9 AND BIORESORBABLE COATING

Biosensors International Group, which is listed on the Mainboard of the Singapore Exchange is pleased to announce that key clinical data from several sources was presented at the Transcatheter Cardiovascular Therapeutics 2005 (TCT) supporting the use of its proprietary antirestinosis drug Biolimus A9 and bioresorbable polymer coating on new drug-eluting stent (DES) platforms.
PR Newswire